Delivery Order SPE2DB22D1106-SPE2DB25FEYW0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,498.25 to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate HFA 110 micrograms in a 12-gram inhaler. This firm fixed price contract, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers. This competitive, firm fixed-price delivery order, valued at $1,079.68, was executed on July 25, 2025, with completion targeted for July 28, 2025. The contract does not carry a set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $4,055.90 to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 21, 2025, just three days after the award date of July 18, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order...
- The U.S. Defense Medical Supply Chain awarded a $1,184.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 mcg inhalers (12 grams) on July 30, 2025, with completion targeted for July 31, 2025. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with the Defense Logistics Agency. The pharmaceutical product will be delivered to the company's...
- The Defense Logistics Agency awarded a $4,535.86 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fluticasone Propionate HFA 220 MCG inhalers (12 grams). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a $4,577.52 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for Fluticasone Propionate HFA 220 MCG inhalers (12 grams). This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with completion targeted for July 25,...
- The Defense Logistics Agency awarded a delivery order valued at $2,245.93 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 MCG inhalers (12-gram units) on July 21, 2025, with completion scheduled for July 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a $2,083.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers. This non-set-aside contract was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for Fluticasone Propionate HFA 110 MCG inhalers (12 grams) with a ceiling value of $2,451.86. This firm fixed-price delivery order, which is non-competitive and non-set-aside, is scheduled for completion by July 31, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,162.96 to AmerisourceBergen Drug Corp for Fluticasone Propionate HFA 220 mcg inhalers (12 grams) with a completion deadline of July 31, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEYW0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Fluticasone Propionate HFA 110 micrograms in 12-gram inhalers, with a contract value of $24,494.88 and an ultimate completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued as a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor vehicle valued at $999,999,999.00 and extending through December 2026. The place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal military and veteran healthcare systems through its pharmaceutical supply chain network. This delivery order is part of the company's extensive portfolio of medical product deliveries supporting the Defense Health Agency and other government healthcare systems. The Fluticasone Propionate inhaler is a respiratory medication commonly used in military and federal healthcare settings, and this order demonstrates AmerisourceBergen's continued role as a primary pharmaceutical supplier for DLA's medical supply chain operations supporting Department of Defense healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.5k | 7/21/25 |